A detailed history of Dudley Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dudley Capital Management, LLC holds 28,122 shares of BMY stock, worth $1.61 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
28,122
Previous 28,122 -0.0%
Holding current value
$1.61 Million
Previous $1.17 Billion 24.58%
% of portfolio
0.75%
Previous 0.65%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$40.25 - $52.99 $1,207 - $1,589
-30 Reduced 0.11%
28,122 $1.17 Billion
Q1 2024

May 13, 2024

SELL
$47.98 - $54.4 $4,078 - $4,624
-85 Reduced 0.3%
28,152 $1.49 Billion
Q2 2023

Aug 09, 2023

BUY
$63.71 - $70.74 $3,822 - $4,244
60 Added 0.21%
28,237 $1.81 Billion
Q1 2023

May 10, 2023

SELL
$65.71 - $74.53 $3,285 - $3,726
-50 Reduced 0.18%
28,177 $1.95 Billion
Q4 2022

Feb 14, 2023

BUY
$68.48 - $81.09 $1.93 Million - $2.29 Million
28,227 New
28,227 $2.03 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Dudley Capital Management, LLC Portfolio

Follow Dudley Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dudley Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dudley Capital Management, LLC with notifications on news.